PofoliaShared via Pofolia

Frontiers in Immunology· 2014Q1· Review

IgG Subclasses and Allotypes: From Structure to Effector Functions

Gestur Vidarsson, Gillian Dekkers, Theo Rispens

Short summary

The four IgG subclasses (IgG1, IgG2, IgG3, IgG4) exhibit distinct effector functions due to variations in their constant regions, impacting FcγR binding, complement activation, and FcRn interactions.

AI-generated from the title and abstract; the full text is not read.

Key points

  • IgG subclasses differ in their constant region structures, especially hinges and upper CH2 domains.
  • These structural variations lead to distinct effector functions, including FcγR binding and complement activation.
  • The Fc-region interacts with FcRn, influencing IgG half-life, placental transport, and mucosal transport.
  • FcRn also participates in myeloid cell functions alongside FcγR and complement.

AI-generated from the title and abstract; the full text is not read.

Abstract

Of the five immunoglobulin isotypes, immunoglobulin G (IgG) is most abundant in human serum. The four subclasses, IgG1, IgG2, IgG3, and IgG4, which are highly conserved, differ in their constant region, particularly in their hinges and upper CH2 domains. These regions are involved in binding to both IgG-Fc receptors (FcγR) and C1q. As a result, the different subclasses have different effector functions, both in terms of triggering FcγR-expressing cells, resulting in phagocytosis or antibody-dependent cell-mediated cytotoxicity, and activating complement. The Fc-regions also contain a binding epitope for the neonatal Fc receptor (FcRn), responsible for the extended half-life, placental transport, and bidirectional transport of IgG to mucosal surfaces. However, FcRn is also expressed in myeloid cells, where it participates in both phagocytosis and antigen presentation together with classical FcγR and complement. How these properties, IgG-polymorphisms and post-translational modification of the antibodies in the form of glycosylation, affect IgG-function will be the focus of the current review.

The authors' abstract, as published at the source. Frontiers in Immunology, 2014 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Radiology, Nuclear Medicine and Imaging

Radiology, Nuclear Medicine and ImagingMedicine